A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2001
10/18/2001	CA2405142A1 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001	CA2405083A1 New bromodomain protein
10/18/2001	CA2405070A1 Estrogen agonist/antagonist metabolites
10/18/2001	CA2404630A1 Cathepsin cysteine protease inhibitors
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403365A1 Quinazoline compounds
10/18/2001	CA2403012A1 Chemical compounds
10/18/2001	CA2401290A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	CA2400740A1 Treatment of skin damage using polyenylphosphatidylcholine
10/18/2001	CA2372352A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/17/2001	EP1146035A1 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
10/17/2001	EP1145718A1 DICARBA-closo-DODECABORANE DERIVATIVES
10/17/2001	EP1145710A1 Use of ascorbic acid derivatives for increasing epidermal ceramides synthesis
10/17/2001	EP1145001A2 (in vitro) model for gastrointestinal inflammation
10/17/2001	EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144617A2 Cancer-associated proteins
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001	EP1144454A2 Modified peptides as therapeutic agents
10/17/2001	EP1144450A1 Mammalian alpha-helical protein - 12
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144435A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144431A2 16-hydroxyestratrienes as selective estrogens
10/17/2001	EP1144427A2 Macrolides with anti-inflammatory activity
10/17/2001	EP1144426A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
10/17/2001	EP1144425A1 Derivatives of monosaccharides as cell adhesion inhibitors
10/17/2001	EP1144421A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
10/17/2001	EP1144412A1 Immunosuppressive effects of pteridine derivatives
10/17/2001	EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001	EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001	EP1144394A1 1-heterocycle substituted diarylamines
10/17/2001	EP1144393A2 Heterocyclic derivatives and their use as integrin inhibitor
10/17/2001	EP1144390A2 Kinase inhibitors
10/17/2001	EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001	EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001	EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144372A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
10/17/2001	EP1144371A1 Benzenesulphonamide derivatives and their use as mek inhibitors
10/17/2001	EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1144348A2 Lta 4? hydrolase inhibitors
10/17/2001	EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001	EP1144011A2 Prodrug compounds and process for preparation thereof
10/17/2001	EP1144008A1 Modulation of systemic memory t cell trafficking
10/17/2001	EP1143994A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
10/17/2001	EP1143985A2 Use of lactobacillus salivarius
10/17/2001	EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
10/17/2001	EP1143973A2 Compositions having improved stability
10/17/2001	EP1143971A1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP1143964A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
10/17/2001	EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
10/17/2001	EP1143958A2 Pharmaceutical composition and use of rnsaid for treating inflammation
10/17/2001	EP1143957A2 Treatment of arthritis with mek inhibitors
10/17/2001	EP1143949A2 19-nor-vitamin d3 compounds with calcemic activity
10/17/2001	EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001	EP1143944A2 Use of arylalkanoylpyridazines
10/17/2001	EP1143943A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
10/17/2001	EP1143942A2 Use of gaba-b receptor ligands for the treatment of neurodegenerative diseases
10/17/2001	EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
10/17/2001	EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001	EP1143928A1 Milling process for the production of finely milled medicinal substances
10/17/2001	EP1143925A1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
10/17/2001	EP1143806A2 Method for increasing pet activity
10/17/2001	EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
10/17/2001	EP0833818B1 3-acylindoles as cb2 receptor agonists
10/17/2001	EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
10/17/2001	CN1318069A Factor VIIa inhibitors
10/17/2001	CN1318059A Isoquinolines as urokinase inhibitors
10/17/2001	CN1318054A Novel compounds
10/17/2001	CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists
10/17/2001	CN1317342A Eye preparation
10/17/2001	CN1317327A Medicinal wine for treating rheumatic and rheumatoid diseases and its preparing prcess
10/17/2001	CN1317321A Medicine for treating intractable ischias and chronic lumbocrural pain and its preparing process
10/17/2001	CN1317320A External-applied Chinese patent medicine, 'Fengshikang' capsule, for treating rheumatalgia and its preparing process
10/17/2001	CN1317316A Powder medicine for treating rheumatoid disease
10/17/2001	CN1073154C Superoxide dismutase-4
10/17/2001	CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof
10/17/2001	CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity
10/17/2001	CN1073098C Benzothiazolone derivatives
10/17/2001	CN1072931C Method of inhibiting cell-cell adhesion
10/17/2001	CN1072930C Compsn. comrising tramadol material and non-steriodal anti-inflammatory drug
10/17/2001	CA2343843A1 Therapeutic light source and method
10/16/2001	US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001	US6303774 Antiviral agents, anticancer agents, metabolic moderators
10/16/2001	US6303659 Administering adamantane derivative for therapy of rheumatoid arthritis
10/16/2001	US6303653 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/16/2001	US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative
10/16/2001	US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system
10/16/2001	US6303636 Arylsulfonylamino hydroxamic acid derivatives
10/16/2001	US6303628 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
10/16/2001	US6303613 As nitric oxide synthase inhibitor useful in therapy or prophylaxis of inflammatory disease and pain
10/16/2001	US6303612 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxphenylsulfanylarylacetic acids
10/16/2001	US6303610 Method of treating gout with certain indole compounds

1 ... 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 ... 1272